The total cost to the NHS of wound care is estimated to be £5.3Bn, with chronic unhealed wounds accounting for the majority of the spend. The variety of wounds and associated treatments present endless challenges in identifying the most appropriate care for efficient healing.
The Yorkshire & Humber Academic Health Science Network (AHSN), together with B Braun, would like to invite you to a wound care information event for NHS staff on Monday 24th September.
Venue: Horizon, 3rd Floor, 2 Brewery Wharf, Kendall Street, Leeds, LS10 1JR
Time: 09:30 – 13:00, Monday 24th September
The event will focus on the national and local issues that the system experiences around wound care management, treatment and associated costs. The event is being held in conjunction with B Braun and will feature information on Prontosan, one of their product ranges for the treatment of wounds. This contributes to the prevention and removal of biofilm, resulting in more efficient and effective wound healing.
The event is intended to be informative, and we would like to hear the views of delegates about their priorities for wound management and treatment, and where improvements can be made.
- Hear about the NHS England’s priorities for making improvements and regional problems faced by wound care management teams
- Discuss methodologies in wound care, and the evidence base for the effectiveness of Prontosan, one of the few products indicated for the prevention and removal of biofilm, a leading cause in delayed healing. Prontosan contains a betaine surfactant, to disrupt and remove the biofilm; and PHMB, a broad spectrum antimicrobial. The Prontosan range has an irrigation solution for wound cleansing and removing biofilm and a gel to prevent biofilm reformation between dressing changes – removing a barrier to wound healing
- Participate in round table discussions to provide your opinion on your organisation’s main problem and priority areas for improving wound care management.
- Two leading tissue viability experts will present on their experience of wound management and the benefits that Prontosan has had in their practice:
- Mark Collier, Nurse Consultant and Associate Lecturer for Tissue Viability will be presenting from the Acute perspective and his work around surgical site infections and how the introduction of the wound cleansing pathway resulted in a decrease of the incidence of a number of bacteria suspected of causing wound infections over a wide spectrum.
- Mark is an Independent Nurse Consultant and Associate Lecturer – Tissue Viability (UK) at the Universities of Hertfordshire and Lincoln. In his last NHS post Mark was responsible for the development of all Tissue Viability services within United Lincolnshire Hospitals NHS Trust, including the development of a pathway to reduce and prevent Surgical Site Infections. Mark has received a number of national and international awards, has over 200 publications to his name and is a member of a number of advisory panels. He is an active member of the NICE Guideline Development Group (GDG) pool and has been involved with the publication of several wound care Guidelines.
- Anita Kilroy-Findley, Clinical Lead for Tissue Viability, Leicestershire Partnership NHS Trust, will be presenting on the community work she has done around introducing a three step biofilm pathway to reduce indiscriminate antimicrobial use and address non healing wounds, and the costs associated with them.
- Anita is the Clinical Lead for a team of 7 TVN’s covering community, mental health, learning disabilities and children. Her particular areas of interest are self-harm, burns, DFU and biofilm wound management. She pioneered a biofilm pathway in response to evidence relating to non-healing wounds and the burden of wound care to the NHS. The pathway has reduced pain, improved exudate levels and ultimately healed ulcers that have often been present for years.
The event is open to NHS staff, and we are particularly keen to hear the views of tissue viability leads, wound care managers, nurses and procurement managers. Please feel free to pass on this invite to colleagues who may be interested in attending.
Please click here to register your attendance.
An outline agenda for the day is below:
|09:30 – 10:00||Registration and networking|
|10:00 – 10:15||The regional and national priorities for improving the management of wound care
Yorkshire & Humber AHSN
|10:15 – 10:25||An overview of Prontosan
|10:25 – 10:45||Mark Collier
Nurse Consultant and Associate Lecturer – Tissue Viability
Universities of Hertfordshire and Lincoln
|10:45 – 11:05||Anita Kilroy-Findley
Clinical Lead Tissue Viability
Leicestershire Partnership NHS Trust
|11:05 – 12:05||Round table discussions on the problem areas and priorities for wound care management.|
|12:05 – 12:15||Closing comments|
|12:15 – 13:00||Networking lunch|
Please note that this event is open to NHS delegates only.
Should you have any queries, please contact firstname.lastname@example.org